Vaccination during pregnancy offers clear COVID-19 protection

Receiving the COVID-19 vaccine during pregnancy may reduce adverse effects among mothers and infants, who are more susceptible to severe disease.

In a study published in JAMA Pediatrics, investigators used January 2024 to May 2025 data from the COVID-19-Associated Hospitalization Surveillance Network to analyze the outcomes of women who received 15%, 50% or 100% COVID-19 vaccination coverage or no vaccination during their second or third trimesters.

At 100% coverage, vaccination was associated with 2,500 and 450 less infant and maternal hospitalizations. However, no vaccination was modeled to result in more than 7,000 infant hospitalizations and 3,000 maternal hospitalizations.

Because of the results of the study, the investigators urged the U.S. Department of Health and Human Services to restore vaccine eligibility for pregnant women.

Read more: JAMA Pediatrics

The article presented here is intended to inform you about the broader media perspective on dentistry, regardless of its alignment with the ADA's stance. It is important to note that publication of an article does not imply the ADA's endorsement, agreement, or promotion of its content.